Trial
NCT02392286
Corticosteroid Dosage for Crohn's Disease Flare
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Yale University
Collaborators
—
Condition
Crohn's Disease
Intervention
Corticosteroid
Why stopped
insufficient enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-08-09